OPPENHEIMER ASSET MANAGEMENT INC. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$650,000
+5.9%
6,535
+1.5%
0.01%
-8.3%
Q3 2020$614,000
+3.4%
6,439
+21.2%
0.01%0.0%
Q2 2020$594,000
+102.7%
5,311
+31.8%
0.01%
+71.4%
Q1 2020$293,000
+215.1%
4,030
+398.1%
0.01%
+250.0%
Q2 2019$93,000
-16.2%
809
-8.4%
0.00%0.0%
Q1 2019$111,000
-26.0%
883
-20.2%
0.00%
-50.0%
Q4 2018$150,000
+265.9%
1,107
+271.5%
0.00%
+300.0%
Q3 2017$41,0002980.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders